In Vivo Antimalarial Activity of the Beta-Carboline Alkaloid Manzamine A

AUTOR(ES)

Ang, Kenny K. H.

FONTE

American Society for Microbiology

RESUMO

Manzamine A, a β-carboline alkaloid present in several marine sponge species, inhibits the growth of the rodent malaria parasite Plasmodium berghei in vivo. More than 90% of the asexual erythrocytic stages of P. berghei were inhibited after a single intraperitoneal injection of manzamine A into infected mice. A remarkable aspect of manzamine A treatment is its ability to prolong the survival of highly parasitemic mice, with 40% recovery 60 days after a single injection. Oral administration of an oil suspension of manzamine A also produced significant reductions in parasitemia. The plasma manzamine A concentration peaked 4 h after injection and remained high even at 48 h. Morphological changes of P. berghei were observed 1 h after treatment of infected mice. (−)-8-Hydroxymanzamine A also displayed antimalarial activity, whereas manzamine F, a ketone analog of manzamine A, did not. Our results suggest that manzamine A and (−)-8-hydroxymanzamine A are promising new antimalarial agents.

Documentos Relacionados

• Benzodiazepine and beta-carboline regulation of single GABAA receptor channels of mouse spinal neurones in culture.
• Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine.
• Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.
• Isolation and identification in bovine cerebral cortex of n-butyl beta-carboline-3-carboxylate, a potent benzodiazepine binding inhibitor.
• Potent antimalarial activity of the alkaloid nitidine, isolated from a Kenyan herbal remedy.